DAPA VILDA 5/100 SR combines Dapagliflozin and Vildagliptin SR, offering a comprehensive approach to managing type 2 diabetes. This dual therapy enhances glycemic control through complementary mechanisms.

How Does It Work?

Dapagliflozin

• Inhibition of SGLT2: Reduces glucose reabsorption in kidneys, promoting excretion.
• Benefits: Lowers blood glucose, aids weight loss, and reduces blood pressure.

Vildagliptin SR

• DPP-4 Inhibition: Increases incretin levels, enhancing insulin secretion and reducing glucagon levels.
• Benefits: Provides prolonged glycemic control and improved postprandial glucose levels.

Uses of DAPA VILDA 5/100 SR

• Glycemic Control: Effective for managing type 2 diabetes.
• Combination Therapy: Used alone or with other antidiabetic medications.
• Cardiovascular and Weight Benefits: Supports heart health and weight reduction.

What is DAPA VILDA 5/100 SR?

A fixed-dose tablet containing 5mg Dapagliflozin and 100mg Vildagliptin SR, targeting different glucose regulation pathways for effective diabetes management.

Side Effects

• Common: UTIs, genital infections, nausea.
• Serious: Ketoacidosis, pancreatitis, allergic reactions.

Safety Information

Precautions

• Monitoring: Regular kidney and liver function tests.
• Hydration: Maintain adequate hydration.

Contraindications

• Hypersensitivity: Avoid in known hypersensitivity.
• Severe Renal Impairment: Not recommended.

Interactions

• Other Antidiabetics: Risk of hypoglycemia with insulin.
• Diuretics: Increased dehydration risk.

Pregnancy and Lactation

• Pregnancy: Not recommended.
• Lactation: Caution advised.

If You Need More Information About  DAPA VILDA 5/100 SR  Click here